ITGAM and Alzheimer disease: Overall, a diversity of drugs including thalidomide [41], pyrazole compound 2-MBAPA [46], angiostatin [47], or antibody treatments including anti-VEGF [48] and anti-MAC-1 antibody for antigen CD11b [49] have been found efficacious in reducing microgliosis in the peptide-injection animal model of AD.